Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for DFTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 1.084B
March 31, 2026 373.42M
December 31, 2025 411.59M
September 30, 2025 209.07M
June 30, 2025 182.99M
March 31, 2025 212.44M
December 31, 2024 273.74M
September 30, 2024 295.28M
June 30, 2024 243.13M
March 31, 2024 252.33M
December 31, 2023 99.70M
September 30, 2023 117.70M
June 30, 2023 116.90M
March 31, 2023 129.41M
December 31, 2022 142.14M
September 30, 2022 154.52M
June 30, 2022 105.74M
March 31, 2022 120.47M
December 31, 2021 133.54M
Date Value
September 30, 2021 145.92M
June 30, 2021 133.54M
March 31, 2021 159.99M
December 31, 2020 80.09M
September 30, 2020 18.24M
June 30, 2020 24.07M
March 31, 2020 20.51M
August 31, 2019 0.0179M
May 31, 2019 0.047M
February 28, 2019 0.3238M
November 30, 2018 0.0156M
August 31, 2018 0.1548M
May 31, 2018 0.1069M
February 28, 2018 0.4053M
November 30, 2017 0.8727M
August 31, 2017 1.691M
May 31, 2017 2.088M
February 28, 2017 1.206M
November 30, 2016 0.3013M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Enliven Therapeutics, Inc. 895.16M
Cocrystal Pharma, Inc. 2.244M
CNBX Pharmaceuticals, Inc. 0.0095M
GB Sciences, Inc. --
Arvinas, Inc. 567.90M